Novonesis AS — Director's Dealing 2017

Jan 26, 2017

Trading by management and of close relations to management

January 26, 2017

Company announcement No. 6

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B

Name	Benny D. Loft
Relation /category of close relation	Executive Vice President and CFO, Corporate Functions
Trading date	January 26, 2017
Market	Nasdaq OMX Copenhagen A/S
Nature of transaction and type of financial instrument	Sale of shares
Volume of transaction buy (+) / sell (-)	-44,778
Value of transaction (DKK)	11,396,091

Contact information

novozymesIR@novozymes.com

Martin Riise

+45 3077 0738

mrsn@novozymes.com

Klaus Sindahl

+45 5363 0134

ksdh@novozymes.com

Nicolai Agerskov Kobborg

+45 3077 1348

niak@novozymes.com

Name	Thomas Videbæk
Relation /category of close relation	Executive Vice President & COO, Research, Innovation & Supply
Trading date	January 25, 2017
Market	Nasdaq OMX Copenhagen A/S
Nature of transaction and type of financial instrument	Sale of shares
Volume of transaction buy (+) / sell (-)	-44,778
Value of transaction (DKK)	11,247,126

About Novozymes

Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com

Novozymes A/S CVR number: 10 00 71 27 LEI: 52990076WNZXD193JW38

Rethink Tomorrow

novozymes A/S

Krogshoejvej 36

2880 Bagsvaerd

Denmark

Phone: +45 4446 0000

novozymes